All news

Wedbush starts Trex Bio at Outperform with $30 target

Alpha Vantage · TradingView · · AI-summarised by FinFlash

Wedbush has initiated coverage of Trex Bio (TRXB) with an Outperform rating and set a price target of $30. This target implies an upside of 118.3% from the stock's closing price of

Read original source

TRXB company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.